Healthcare / Medical Care FacilitiesXETRA
$505.00
-10.00 (-1.94%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 21%
FCF escenarios
weak_data · normalized FCF $1.1M · quality 45.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
61/100
B
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$150M
P/E
26.4x
↑EV/EBITDA
11.8x
↓ROE
22.5%
↑Gross Margin
91.9%
↑Debt/Equity
0.42
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+20.2%
FCF CAGR
-44.6%
FCF margin
2.3%
FCF / Net income
0.20x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $50.0M · net income $5.7M · FCF $1.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $50.0M | $50.0M | $37.5M | $37.2M | $28.8M |
| Net Income | $5.7M | $5.7M | $3.1M | $3.4M | $4.2M |
| EBITDA | $12.8M | $12.8M | $7.1M | $7.7M | $4.6M |
| EPS | 19.11 | 19.11 | 10.61 | 11.58 | 14.34 |
| Gross Margin | 91.9% | 91.9% | 92.1% | 90.8% | 90.2% |
| Operating Margin | 18.6% | 18.6% | 11.5% | 13.5% | 6.7% |
| Net Margin | 11.4% | 11.4% | 8.3% | 9.1% | 14.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.42 | 0.42 | 0.57 | 0.67 | 0.81 |
| Current Ratio | 4.13 | 4.13 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.1M | $1.1M | $2.5M | $-3.5M | $6.7M |
| Returns | |||||
| ROE | 22.5% | 22.5% | 17.0% | 22.5% | 37.9% |
| Valuation | |||||
| P/E | 26.43 | 26.43 | 32.23 | 25.56 | 22.87 |
| EV/EBITDA | 11.79 | 11.79 | 14.16 | 11.52 | 20.51 |
| P/B | 5.94 | 5.94 | 5.47 | 5.74 | 8.66 |
| Growth & Yield | |||||
| Revenue Growth | 33.5% | 33.5% | 0.8% | 29.0% | — |
| EPS Growth | 80.1% | 80.1% | -8.4% | -19.2% | — |
| Dividend Yield | 1.9% | 1.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
32.9%
EPS terminal req.
$44.81
Spread vs growth
47.3%
5Y implied EPS CAGR
23.2%
EPS terminal req.
$54.22
Spread vs growth
56.9%
10Y implied EPS CAGR
16.4%
EPS terminal req.
$87.32
Spread vs growth
63.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+54.0%
Start / end P/E
31.3x → 26.4x
EPS bridge
10.61 → 19.11
Residual
-12.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.